Global Generic Pharmaceuticals Market Size & Outlook
Global generic pharmaceuticals market, 2018-2028 (US$M)
Related Markets
Global generic pharmaceuticals market highlights
- The global generic pharmaceuticals market generated a revenue of USD 310.4 million in 2020 and is expected to reach USD 614.6 million by 2028.
- The market is expected to grow at a CAGR (2021 - 2028) of 8.9% by 2028.
- In terms of segment, simple generic accounted for a revenue of USD 225.3 million in 2020.
- Biosimilars is the most lucrative type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2020.
- Country-wise, South Africa is expected to register the highest CAGR from 2021 to 2028.
Global data book summary
| Market revenue in 2020 | USD 310.4 million |
| Market revenue in 2028 | USD 614.6 million |
| Growth rate | 8.9% (CAGR from 2020 to 2028) |
| Largest segment | Simple generic |
| Fastest growing segment | Biosimilars |
| Historical data covered | 2018 - 2019 |
| Base year for estimation | 2020 |
| Forecast period covered | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Simple Generic, Specialty Generics, Biosimilars |
Other key industry trends
- In terms of revenue, the North America accounted for 33.0% of the global generic pharmaceuticals market in 2020.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2028.
- By country, South Africa is the fastest growing regional market and is projected to reach USD 7.2 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Generic Pharmaceuticals Market Scope
Generic Pharmaceuticals Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global generic pharmaceuticals market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to generic pharmaceuticals market will help companies and investors design strategic landscapes.
Simple generic was the largest segment with a revenue share of 72.58% in 2020. Horizon Databook has segmented the Global generic pharmaceuticals market based on simple generic, specialty generics, biosimilars covering the revenue growth of each sub-segment from 2018 to 2028.
- Global Generic Pharmaceuticals Type Outlook (Revenue, USD Million, 2018-2028)
- Simple Generic
- Specialty Generics
- Biosimilars
- Global Generic Pharmaceuticals Application Outlook (Revenue, USD Million, 2018-2028)
- Central Nervous System Disorders
- Respiratory Diseases
- Hormones and Related Diseases
- Gastrointestinal Diseases
- Cardiovascular Diseases
- Infectious Diseases
- Cancer
- Diabetes
- Other
- Global Generic Pharmaceuticals Product Outlook (Revenue, USD Million, 2018-2028)
- Small Molecule
- Large Molecule
- Global Generic Pharmaceuticals Route of Administration Outlook (Revenue, USD Million, 2018-2028)
- Oral
- Injectable
- Inhalable
- Others
- Global Generic Pharmaceuticals Distribution Channel Outlook (Revenue, USD Million, 2018-2028)
- Online Pharmacies
- Retail Pharmacies
- Hospital Pharmacies
Reasons to subscribe to Global generic pharmaceuticals market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global generic pharmaceuticals market databook
-
Our clientele includes a mix of generic pharmaceuticals market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global generic pharmaceuticals market , including forecasts for subscribers. This global databook contains high-level insights into Global generic pharmaceuticals market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
Global generic pharmaceuticals market size, by region, 2018-2028 (US$M)
Top 10 countries: Generic pharmaceuticals market size, 2020 (US$M)
Global generic pharmaceuticals market share, by type, 2020 & 2028 (%, US$M)
Generic pharmaceuticals market: Opportunity assessment by country
Global generic pharmaceuticals market, by region, 2020 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
